Alan Glicklich M.D.
Net Worth
Last updated:
What is Alan Glicklich M.D. net worth?
The estimated net worth of Dr. Alan Glicklich M.D. is at least $1,787,064 as of 11 Feb 2022. He has earned $38,864 from insider trading and has received compensation worth at least $1,748,200 in Chinook Therapeutics, Inc..
What is the salary of Alan Glicklich M.D.?
Dr. Alan Glicklich M.D. salary is $437,050 per year as Chief Medical Officer in Chinook Therapeutics, Inc..
How old is Alan Glicklich M.D.?
Dr. Alan Glicklich M.D. is 63 years old, born in 1962.
What stocks does Alan Glicklich M.D. currently own?
As insider, Dr. Alan Glicklich M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Chinook Therapeutics, Inc. (KDNY) | Chief Medical Officer | 7,891 | $0 | $0 |
What does Chinook Therapeutics, Inc. do?
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.
Alan Glicklich M.D. insider trading
Chinook Therapeutics, Inc.
Dr. Alan Glicklich M.D. has made 2 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 2,391 units of KDNY stock worth $30,464 on 11 Feb 2022.
The largest trade he's ever made was exercising 20,000 units of KDNY stock on 16 Jun 2021. As of 11 Feb 2022 he still owns at least 7,891 units of KDNY stock.
Chinook Therapeutics key executives
Chinook Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Alan Glicklich M.D. (63) Chief Medical Officer
- Mr. Eric L. Dobmeier (56) Pres, Chief Executive Officer & Director
- Mr. Tom Frohlich (49) Chief Operating Officer